1Blade J,Cibeira MT,Rosinol L. Bortezomib :a valuable new antineoplastie strategy in multiple myeloma [J]. Acta Oncol,2005,44 (5) :440-408.
2Ludwig H, Khayat D, Giaccone G, et al. Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies [J]. Cancer, 2005, 104 (9) : 1794-1807.
3Jackson G, Einsele H, Moreau P, et al. Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies [J]. Cancer Treat Rev, 2005,31(8):591-602.
4Montagut C, Rocira A, Albanell J. The proteasome: a novel target for antieaneer therapy [J]. Clin Transl Oncol, 2006,8(5) :313-317.
5Mai W, Meng H, Jin J, et al. Treatment with bortezomib in a patient with heavily pretreated refractory T-cell lymphoblastic lymphoma [J]. Eur J Haematol, 2006,77 (5) : 445-447.
